Aesthetic Medicine and Plastic Surgery
https://ojs.luminescience.cn/AMPS
<p class="MsoNormal"><em>Aesthetic Medicine and Plastic Surgery</em><span lang="EN-US"> (AMPS) is an open access, international journal dedicated to serving as a forum for clinical researchers, surgeons, cosmetic physicians and practitioners to update the latest procedures, and new techniques in the fields of aesthetic medicine and plastic surgery. AMPS publishes peer-reviewed original articles, reviews, case reports, research highlights, communications, commentaries and technical notes. Manuscripts with videos are also welcomed.</span></p>
en-US
Aesthetic Medicine and Plastic Surgery
<p>Copyright licenses detail the rights for publication, distribution, and use of research. Open Access articles published by Luminescience do not require transfer of copyright, as the copyright remains with the author. In opting for open access, the author(s) should agree to publish the article under the CC BY license (Creative Commons Attribution 4.0 International License). The CC BY license allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license, users are free to share (copy, distribute and transmit) and remix (adapt) the contribution, including for commercial purposes, providing they attribute the contribution in the manner specified by the author or licensor.</p>
-
Facing tomorrow – where evidence based plastic surgery meets aesthetic and longevity medicine
https://ojs.luminescience.cn/AMPS/article/view/124
Dominik Duscher
Copyright © 2022 Dominik Duscher
https://creativecommons.org/licenses/by/4.0
2022-09-09
2022-09-09
3
4
-
Regenerative plastic surgery
https://ojs.luminescience.cn/AMPS/article/view/98
Pietro Gentile
Copyright © 2022 Pietro Gentile
https://creativecommons.org/licenses/by/4.0/
2022-08-04
2022-08-04
1
2
-
A rare case of lipofilling of the breast and cystic DCIS
https://ojs.luminescience.cn/AMPS/article/view/142
<p><strong>Bac</strong><strong>kground</strong><strong>: </strong>Autologous fat grafting for primary breast augmentation has become a standard procedure among plastic surgeons. Sometimes the fat graft take fails and subsequent tissue alterations can interfere with the diagnostics of pathological changes.</p> <p><strong>Methods/ Results</strong><strong>: </strong>A 49-year-old patient presented with a palpable mass in her left breast 7 years after lipofilling augmentation. The ultrasound examination showed small cystic lesions. Fine needle aspirations and a core biopsy was non-diagnostic. The cystic lesion reappeared, and a surgical excision revealed the diagnosis of an intermediate grade DCIS.</p> <p><strong>Conclusion</strong><strong>: </strong>After lipofilling, any suspicious lumps might need more vigilant observation, as common benign post-lipofilling findings like cysts or calcifications may hide malignant pathology.</p>
Sora Linder
Kristina Bolten
Zsuzsanna Varga
Hisham Fansa
Copyright © 2023 Sora Linder, Kristina Bolten, Zsuzsanna Varga, Hisham Fansa
https://creativecommons.org/licenses/by/4.0
2023-07-18
2023-07-18
13
16
-
A pilot study testing efficacy and tolerability of hybrid cooperative complexes of hyaluronic acid intradermal injections in Chinese women
https://ojs.luminescience.cn/AMPS/article/view/168
<p><strong>Objective</strong>: To assess the efficacy and tolerability of a hyaluronic acid (HA)-based injectable formulation of stable hybrid cooperative complexes of high (H-HA) and low (L-HA) molecular weight HA (32 mg of H-HA and 32 mg of L-HA) produced by NAHYCO<sup>®</sup> Hybrid Technology (Profhilo<sup>®</sup><sup>, </sup>hereinafter referred to as "The product"), for the treatment of wrinkles, roughness and laxity of the skin of the face and neck areas in women of Chinese ethnicity resident in Italy.</p> <p><strong>Methods</strong>: 28 women from 30 to 60 years of age were enrolled, 18 for the neck area and 10 for the face. The self-isolation of the included subjects due to the COVID-19 pandemic outbreak prevented the completion of the trial as to the approved protocol, which scheduled a follow-up until week 16 after baseline, and amendments to original plan were necessary. The product<sup> </sup>was intradermally injected in 2 sessions, 4 weeks apart, assessments were performed at 4, and 8 weeks after the first injection as to the neck, while 3 subjects were evaluated until week 12 for the face. Wrinkle Severity Rating Scale (WSRS), Facial Volume Loss Score (FVLS) were used to clinically assess results for the face, while the IBSA Neck Laxity Scale was used for neck evaluation; superficial and deep hydration were assessed by a corneometer and a moisturemeter while skin color changes of the face were measured with a spectrophotometer; all these evaluations were supported by 3D photographic documentation.</p> <p><strong>Results</strong>: Data showed overall improvement of the evaluated parameters already after the first round of treatment both at the facial and neck level, with a benefit that was kept or increased after the second session, with a very high tolerability profile. Although the amelioration trend was clearly visible, the obtained data are not statistically significant, probably due to the COVID-19 pandemic outbreak that prevented to analyze results from a larger population.</p> <p><strong>Conclusions</strong>: Despite further analysis are required, the product injections could represent a promising treatment to induce skin amelioration in both face and neck areas in Chinese women, and it was well-tolerated.</p>
Adele Sparavigna
Roberto Lualdi
Marco Cicerone
Andrea Maria Giori
Gilberto Bellia
Copyright © 2023 Adele Sparavigna, Roberto Lualdi, Marco Cicerone, Andrea Maria Giori, Gilberto Bellia
https://creativecommons.org/licenses/by/4.0
2023-07-03
2023-07-03
5
12